Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T18:01:50.284Z.
Calculation as of: 2026-10-06T18:01:50.284Z.
Quote observation: 2026-10-06T18:00:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e78bbdb3a8988fdd9fdd63a4dcf124b38851ed281a9b1f93071349952e7e00d5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$44.40M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$45.20M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.38M
Price/FCF Ratio
10.22
TTM Avg
33.81
3Y Avg
4688.00
5Y Avg
4688.00
Market Cap
$43.22M
Price/FCF Ratio
N/A
TTM Avg
19.80
3Y Avg
20.69
5Y Avg
119.64
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.45M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.40M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $43.88M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.51M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $43.38M | 10.22 | 33.81 | 4688.00 | 4688.00 |
| BioStem Technologies, Inc. (BSEM)vs › | $43.22M | N/A | 19.80 | 20.69 | 119.64 |
| Precipio, Inc. (PRPO)vs › | $42.15M | 53.42 | 75.00 | 61.77 | 61.77 |
| Instil Bio, Inc. (TIL)vs › | $47.27M | N/A | N/A | N/A | N/A |
| Veru Inc. (VERU)vs › | $41.09M | N/A | 6899.49 | 6899.49 | 3477.73 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
